16.2
Bristol-Myers Squibb Company
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
13.1
FY23:
13.9
FY24:
15.2
FY25:
14.2
Change from FY21 to FY25
billions USD
FY21:
−0.54
FY22:
−1.06
FY23:
−2.30
FY24:
−21.4
FY25:
−4.13
Change from FY21 to FY25
billions USD
FY21:
−16.2
FY22:
−17.0
FY23:
−9.42
FY24:
5.13
FY25:
−10.3
billions USD
FY21:
−0.66
FY22:
−4.99
FY23:
2.19
FY24:
−1.17
FY25:
−0.13
(positive)
Change from FY21 to FY25
billions USD
FY21:
15.2
FY22:
11.9
FY23:
12.7
FY24:
13.9
FY25:
12.8
All amounts in billions USD